Streetbeat News

Stock Prices

BABA

Alibaba Group shares are trading lower following a Q1 revenue miss.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:11 am

CSCO

Cisco Systems shares are trading higher following better-than-expected Q4 earnings.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:10 am

QURE

uniQure has dosed the first patient in its Phase I/IIa clinical trial of AMT-191, a gene therapy for Fabry disease. This marks a significant milestone in the development of treatments for this rare genetic disorder.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:09 am

CLBT

Cellebrite DI (NASDAQ:CLBT) reported Q2 2024 earnings of $0.10 per share, doubling the analyst estimate of $0.05. Sales reached $95.714 million, surpassing the $91.963 million estimate and marking a 24.82% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:08 am

TGT

WMT

Target shares are trading higher following strong earnings from Walmart.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:07 am

RNAZ

TransCode Therapeutics has announced the initiation of a Phase 1 study for its lead therapeutic candidate, TTX-MC138. This study marks a significant milestone for the company as it advances its clinical pipeline.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:06 am

WMT

Walmart has raised its FY25 adjusted EPS outlook to $2.35-$2.43 from the previous $2.23-$2.37, aligning closely with the $2.43 estimate. The company also updated its consolidated net sales growth to 3.75%-4.75% and adjusted operating income growth to 6.5%-8.0%.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:05 am

CVAC

CureVac has advanced its cancer vaccine candidate CVGBM to Part B of its Phase 1 study in patients with resected glioblastoma. The first patient has been administered the dose-confirmation, and Part B is expected to include up to 20 patients to gather extended data on safety, tolerability, and immunogenicity.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:05 am

GAMB

Gambling.com Group shares are trading higher following better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:05 am

GAMB

Gambling.com Group (NASDAQ:GAMB) reported Q2 2024 adjusted EPS of $0.20, beating the $0.12 estimate by 66.67%. Sales were $30.541M, surpassing the $26.909M estimate by 13.50%. Both EPS and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:04 am